| Residential College | false |
| Status | 已發表Published |
| ADME/DMPK in the development and use of tyrosine and serine-threonine kinase inhibitors | |
Godefridus J. Peters1 ; Kin Tam2
| |
| 2016 | |
| Source Publication | ADMET & DMPK
 |
| ISSN | 1848-7718 |
| Volume | 4Issue:3Pages:182-185 |
| DOI | 10.5599/admet.4.3.348 |
| Indexed By | SCIE |
| Language | 英語English |
| WOS Research Area | Pharmacology & Pharmacy |
| WOS Subject | Pharmacology & Pharmacy |
| WOS ID | WOS:000447338500001 |
| Scopus ID | 2-s2.0-85047052647 |
| Fulltext Access | |
| Citation statistics | |
| Document Type | Journal article |
| Collection | Faculty of Health Sciences |
| Corresponding Author | Godefridus J. Peters; Kin Tam |
| Affiliation | 1.Department of Medical Oncology, VU University Medical Center, Amsterdam, the Netherlands 2.Faculty of Health Sciences, University of Macau, Taipa, Macau |
| Corresponding Author Affilication | Faculty of Health Sciences |
| Recommended Citation GB/T 7714 | Godefridus J. Peters,Kin Tam. ADME/DMPK in the development and use of tyrosine and serine-threonine kinase inhibitors[J]. ADMET & DMPK, 2016, 4(3), 182-185. |
| APA | Godefridus J. Peters., & Kin Tam (2016). ADME/DMPK in the development and use of tyrosine and serine-threonine kinase inhibitors. ADMET & DMPK, 4(3), 182-185. |
| MLA | Godefridus J. Peters,et al."ADME/DMPK in the development and use of tyrosine and serine-threonine kinase inhibitors".ADMET & DMPK 4.3(2016):182-185. |
| Files in This Item: | There are no files associated with this item. | |||||
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment